Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Vaxcyte, Inc.

Clinical trials sponsored by Vaxcyte, Inc., explained in plain language.

Vaxcyte, Inc. PCVX NASDAQ

A biopharmaceutical company developing vaccines to prevent bacterial infections.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 4 Completed 1
Sort by
  • New 24-Strain pneumonia vaccine shows promise in infant trial

    ⭐️ VACCINE ⭐️ Completed

    This study tested a new vaccine called VAX-24, which targets 24 types of pneumococcal bacteria, in 802 healthy infants. The babies received four doses at 2, 4, 6, and 12-15 months old, alongside routine vaccines. The goal was to check safety and how well the vaccine triggers an i…

    Phase: PHASE2 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️

    Last updated Jun 26, 2026 16:37 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space